RBP4 and metabolic syndrome: In humans, circulating RBP4 levels have been shown to be negatively correlated with levels of insulin sensitivity, and to be higher among individuals with obesity and type 2 diabetes, as well as among those with adverse CVD risk factor profiles or metabolic syndrome, frequently independent of body size [6-14].